Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Naomichi Okamoto

Datos Biográficos

ID7112277
NOMBRENaomichi Okamoto
NOMBRESNaomichi
APELLIDOOkamoto
FIRMAOKAMOTO N
AFILIACIONESUniversity of Occupational and Environmental Health Japan
ORCID0000-0003-2791-8113
VERIFICADOSí
TOTAL DE OBRAS7
TOTAL DE CITAS0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0
  • Fronto-striato network function is reduced in major depressive disorder

    Open Access•Reoto Kijima, Keita Watanabe et al.•ARTICLE•Frontiers in Psychiatry•2024

    The reward system function is decreased in MDD patients, and this decrease may be more pronounced in younger patients, although further research is still needed

  • Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder

    Open Access•Enkhmurun Chibaatar, Keita Watanabe et al.•ARTICLE•Frontiers in Psychiatry•2023

    This is the first research study to investigate alterations of the various thalamic nuclei volumes in MDD patients compared with HCs. Moreover, we first analyzed the association between individual thalamic nuclei volumes and HAM-D subscale scores. Though our study may be restricted at certain levels, especially by the demographic difference between the two groups, they possibly contribute at a preliminary level to understanding the thalamic struc…

  • Gyrification patterns in first-episode, drug-naïve major depression

    Open Access•Tomoya Natsuyama, Naomichi Okamoto et al.•ARTICLE•Frontiers in Psychiatry•2023

    These results suggest that abnormal early cortical neurodevelopment may mediate vulnerability to MDD, independent of plasma BDNF levels and depressive symptoms

  • Risk Factors in Japanese Drug Overdose Patients

    Open Access•Naomichi Okamoto, Atsuko Ikenouchi et al.•ARTICLE•OMEGA - Journal of Death and Dying•2023

    Several suicide attempts presented at the emergency department are due to drug overdose associated with psychiatric disorders. We examined and identified the major risk factors among Japanese drug overdose patients and several close associations of suicide risk. We enrolled 101 patients who attempted suicide by drug overdose between January 2015 and April 2018, assessed their background using the SAD PERSONS scale, and performed association rule …

  • Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Tomoya Natsuyama et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: The kynurenine (Kyn) pathway may play a role in the pathophysiology of schizophrenia. This pathway shows crosstalk with proinflammatory cytokines, including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), and/or brain-derived neurotrophic factor (BDNF). Moreover, Kyn metabolites affect neurotransmission and cause neurotoxicity. To date, the influence of the Kyn pathway on proinflammatory cytokines and BDNF remains to b…

  • Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Koji Yoshino et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Insulin-like growth factor 1 (IGF-1) is a trophic mediator that is regulated by growth hormone and associated with the proliferation, development, and growth of neural cells. IGF-1 may be associated with the pathophysiology of schizophrenia, but this association remains controversial. This study aimed to investigate the relationship between serum IGF-1 levels and psychiatric symptoms in patients with chronic schizophrenia. Patients and M…

  • A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Atsuko Ikenouchi et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Metabolomics has attracted attention as a new method for understanding the molecular mechanisms of psychiatric disorders. Current metabolomics technology allows us to measure over hundreds of metabolites at a time and is a useful indicator of the consequences of complex and continuous changes in metabolic profiles due to the execution of genomic information and external factors of biological activity. Therefore, metabolomics is imperativ…

Sin obras prominentes en esta página.

  • Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Tomoya Natsuyama et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: The kynurenine (Kyn) pathway may play a role in the pathophysiology of schizophrenia. This pathway shows crosstalk with proinflammatory cytokines, including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), and/or brain-derived neurotrophic factor (BDNF). Moreover, Kyn metabolites affect neurotransmission and cause neurotoxicity. To date, the influence of the Kyn pathway on proinflammatory cytokines and BDNF remains to b…

  • Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Koji Yoshino et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Insulin-like growth factor 1 (IGF-1) is a trophic mediator that is regulated by growth hormone and associated with the proliferation, development, and growth of neural cells. IGF-1 may be associated with the pathophysiology of schizophrenia, but this association remains controversial. This study aimed to investigate the relationship between serum IGF-1 levels and psychiatric symptoms in patients with chronic schizophrenia. Patients and M…

  • A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia

    Open Access•Naomichi Okamoto, Atsuko Ikenouchi et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Metabolomics has attracted attention as a new method for understanding the molecular mechanisms of psychiatric disorders. Current metabolomics technology allows us to measure over hundreds of metabolites at a time and is a useful indicator of the consequences of complex and continuous changes in metabolic profiles due to the execution of genomic information and external factors of biological activity. Therefore, metabolomics is imperativ…

  • Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder

    Open Access•Enkhmurun Chibaatar, Keita Watanabe et al.•ARTICLE•Frontiers in Psychiatry•2023

    This is the first research study to investigate alterations of the various thalamic nuclei volumes in MDD patients compared with HCs. Moreover, we first analyzed the association between individual thalamic nuclei volumes and HAM-D subscale scores. Though our study may be restricted at certain levels, especially by the demographic difference between the two groups, they possibly contribute at a preliminary level to understanding the thalamic struc…

  • Gyrification patterns in first-episode, drug-naïve major depression

    Open Access•Tomoya Natsuyama, Naomichi Okamoto et al.•ARTICLE•Frontiers in Psychiatry•2023

    These results suggest that abnormal early cortical neurodevelopment may mediate vulnerability to MDD, independent of plasma BDNF levels and depressive symptoms

  • Risk Factors in Japanese Drug Overdose Patients

    Open Access•Naomichi Okamoto, Atsuko Ikenouchi et al.•ARTICLE•OMEGA - Journal of Death and Dying•2023

    Several suicide attempts presented at the emergency department are due to drug overdose associated with psychiatric disorders. We examined and identified the major risk factors among Japanese drug overdose patients and several close associations of suicide risk. We enrolled 101 patients who attempted suicide by drug overdose between January 2015 and April 2018, assessed their background using the SAD PERSONS scale, and performed association rule …

  • Fronto-striato network function is reduced in major depressive disorder

    Open Access•Reoto Kijima, Keita Watanabe et al.•ARTICLE•Frontiers in Psychiatry•2024

    The reward system function is decreased in MDD patients, and this decrease may be more pronounced in younger patients, although further research is still needed

Medicine (7 obras) · Psychiatry (7 obras) · Internal Medicine (6 obras) · Psychology (4 obras) · Tryptophan and brain disorders (4 obras) · Functional Brain Connectivity Studies (3 obras) · Major depressive disorder (3 obras) · Schizophrenia (object-oriented programming (3 obras) · Biology (2 obras) · Brain-derived neurotrophic factor (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae